An Update on Starpharma - ASX:SPL

Friday, August 30, 2019 1:30 AM +00:00

STARPHARMA HOLDINGS LIMITED
Dr Jackie Fairley

Starpharma Holdings Limited (ASX: SPL, OTCQX:SPHRY), located in Melbourne Australia, is an ASX 300 company and is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications. Starpharma’s underlying technology is built around dendrimers – a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical and medical uses. Starpharma has two core development portfolios: VivaGel® portfolio and DEP® drug delivery with the Company developing several products internally and others via commercial partnerships.


Leave a Comment

Your email address will not be published

WEBCAST Calendar

  • 2 Dec

    02:00

    Quantify Technology (ASX:QFY) discusses Honeywell MOU & BLAQ partnership

    QUANTIFY TECHNOLOGY HOLDINGS LIMITED
  • 2 Dec

    02:00

    Zelira Therapeutics on its acquisition with Ilera

    ZELIRA THERAPEUTICS LTD
  • 2 Dec

    02:00

    Resolute Mining - The World's First Fully Automated Gold Mine.

    RESOLUTE MINING LIMITED
  • 2 Dec

    02:00

    Powering Smart Hospitals with AI at the Edge

    NVIDIA CORPORATION
  • 2 Dec

    02:00

    The Assay TV: Scott Williamson, Blackstone Minerals

    BLACKSTONE MINERALS LIMITED